Hillyer Shahab, Gulmi Frederick A
Department of Urology, Brookdale University Hospital and Medical Center, Brooklyn, New York, USA.
Can J Urol. 2009 Oct;16(5):4866-9.
Transitional cell carcinoma of the bladder is commonly treated with intravesical BCG. We report a cutaneous complication of BCG after therapy in 66-year-old male 4 years after initiating treatment.
A case review including pathological slides, laboratory data, and radiographic findings.
Biopsy findings showed an ill defined granulomatous process with chronic inflammation and necrosis.
The patient was managed on antituberculous therapy for a period of 6 months with resolution of symptoms.